A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge

J Med Chem. 2002 Sep 26;45(20):4391-4. doi: 10.1021/jm025549i.

Abstract

Replacing Cys(5) by Pen (penicillamine, beta,beta-dimethylcysteine) in the cyclic C-terminal U-II octapeptide, U-II(4-11), we have obtained a potent urotensin II (U-II) receptor agonist. Conformational analysis of solution NMR data indicated that the putative biologically active conformation of U-II is stabilized by introduction of a Pen residue. To the best of our knowledge, this is the most potent U-II receptor agonist reported to date.

MeSH terms

  • Animals
  • Binding, Competitive
  • CHO Cells
  • Cricetinae
  • Cysteine / chemistry
  • Disulfides / chemistry*
  • Humans
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Molecular Conformation
  • Oligopeptides / chemical synthesis*
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology
  • Penicillamine / chemistry*
  • Peptides, Cyclic / chemical synthesis*
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / pharmacology
  • Radioligand Assay
  • Receptors, Cell Surface / agonists*
  • Receptors, G-Protein-Coupled*
  • Structure-Activity Relationship

Substances

  • Disulfides
  • Oligopeptides
  • Peptides, Cyclic
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • UTS2R protein, human
  • aspartyl-cyclo(penicillamyl-phenylalanyl-tryptophyl-lysyl-tyrosyl-cysteinyl)valine
  • Penicillamine
  • Cysteine